The fitness-tracking ring is the talk of the C-suite. Get ready to muscle in
Review could be used to build support for health secretary’s reform plans
Are you a Hot Bibber? Or a Hall of Famer? When it comes to the 26-mile club, we’ve found the running tribe for you
Decision to associate charity with a cure turned it into Europe’s biggest funder of dementia research
The Japanese mindfulness practice has found a natural home in this corner of tree-cloaked British Columbia
New compound increases strength of antidote for fentanyl and other lethal drugs
New agreement hands UK drugmaker control of developing jabs and provides cash injection for German group
New drug Kisunla will be 20% more than rival as drugmaker claims it requires fewer treatments
Pfizer and BioNTech infringed pharmaceutical group’s mRNA patent, High Court in London rules
From traditional styling in The Hamptons to a high-design compound in Montauk
Federal health officials step up efforts to boost jab stockpiles in response to widening outbreak
Party will look to align health service in England more closely with DHSC in bid to cut waiting lists if it wins election
If the Grim Reaper is coming for you, there’s not much money can do to prevent it
Neurotech advance gives patients in MIT study walking speed and control closer to people who had not lost limbs
Sale of most of FairJourney Biologics means London-based owner GHO Capital realises close to 10-fold return
Employers are often less flexible with staff who need to care for older children
Information about patients remains ‘liquid gold’ when it comes to enriching medical research
Pharma group dealt another blow following decision by British to award vaccine contract to rival Pfizer
Document obtained by Bloomberg suggests court will allow emergency abortions
Innovative takes on the green tea trend
Discovery could allow more precise and efficient targeting of DNA modifications
Danish maker of Wegovy has little competition in the country and massive demand that it can take advantage of
Move opens market with growing rates of obesity to Danish group’s blockbuster drug
US 2022 abortion ruling has heightened concerns over the safety of women’s healthcare trackers
Danish pharma group plans 1.4mn sq ft manufacturing plant in North Carolina to help meet surging demand
International Edition
